Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 9, 2012癌症：英文版Open Access

Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology

View Full Paper
Ask AI
Bookmark
Share

Authors

XXXue XueNanjing Agricultural UniversityXing‐Jie LiangXing‐Jie LiangBeijing Institute of Technology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Xue et al. (2012) studied this question.

synapsesocial.com/papers/6a7738222e130d02afec7118https://doi.org/10.5732/cjc.011.10326
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Nanomedicine: current status and future prospects2005 · 2,025 citations
  2. 2The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity2004 · 566 citations
  3. 3The Role of ABC Transporters in Clinical Practice2003 · 830 citations